Letters
How much will Herceptin really cost?
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39051.733715.3A (Published 07 December 2006) Cite this as: BMJ 2006;333:1219
Balancing local and national priorities is not new
- Andrew Dillon (lucy.betterton@nice.org.uk),
- Peter Littlejohns, clinical and public health director
- 1National Institute for Health and Clinical Excellence, London WC1V 6NA
Herceptin for early stage breast cancer is a cost effective treatment, and it is right that the NHS should make it available. The challenge of funding new treatments and balancing local and national priorities is one the NHS has faced since its inception.1 …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.